---

Retrospective analysis on adverse drug reactions prevalence in the female population of Tertiary Care Hospital

---

Original Article

Author Details : Rangeel Singh Raina, Sona Bharti Kaushal

Volume : 5, Issue : 1, Year : 2018

Article Page : 40-43

https://doi.org/10.18231/2393-9087.2018.0010

Suggest article by email

Get Permission

---

Abstract

Introduction: Adverse drug reactions seems to be a major problem in women than men.
Objective: This study as planned to assess the incidence rate, clinical manifestations, and causative agents for adverse drug reactions (ADRs) in female patients.
Materials and Methods: This study was a retrospective study in which analysis of the clinical variables related to all suspected cases of ADRs reported in female patients of the tertiary centre hospital.
Results: Out of 206 patients reported with ADR in between period of 2012 to 2015, 110 (53.4%) were female whereas only 46.6% were male patients. Although Mean age of female patients affected from ADRs was 31.53 years and most of ADRs were reported in the age group of 20-39 years (41.8%).Department of dermatology has reported maximum number of ADRs in females (51, 46.36%), followed by medicine (21, 23.6%) and Surgery (19, 17.02%). Amongst 85 ADRs cases reported due to antimicrobial, betalactams (31, 36.5%) and quinolones (17, 20%) were the mostly responsible, followed by aminoglycosides (11, 12.9%). Skin was affected more frequently (69.6%), followed by gastrointestinal (14.9%).

Conclusion: Adverse drug reactions in female seems to be a significant problem and we need to evaluates the physiological and other cofactors to understand the high occurrence of adverse drug reaction in females.

Keywords: Adverse Drug Reactions, woman, Pharmacovigilance, prevalence.

How to cite : Raina R S, Kaushal S B, Retrospective analysis on adverse drug reactions prevalence in the female population of Tertiary Care Hospital. Indian J Pharm Pharmacol 2018;5(1):40-43

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.